- Home
- ARR vs AXGN Comparison
ARR vs AXGN Comparison
Compare ARR & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARR | AXGN |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARR | AXGN |
|---|---|---|
| Price | $16.64 | $40.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $18.50 | ★ $42.33 |
| AVG Volume (30 Days) | ★ 2.8M | 895.8K |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | ★ 16.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.57 |
| Revenue Next Year | N/A | $16.68 |
| P/E Ratio | $27.18 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $13.98 | $9.22 |
| 52 Week High | $19.31 | $45.83 |
Technical Indicators
Market Signals| Indicator | ARR | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 53.56 |
| Support Level | $16.28 | $39.52 |
| Resistance Level | $17.76 | $45.14 |
| Average True Range (ATR) | 0.27 | 1.59 |
| MACD | -0.11 | -0.38 |
| Stochastic Oscillator | 30.98 | 28.37 |
Price Performance
Historical ComparisonAbout ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.